EUVIMEDDescoperă EUVIMED
Crossref

Hesperidin Inhibits Oxidative Stress and Apoptosis of Granulosa Cells in Polycystic Ovarian Syndrome Through the JAK2 / STAT3 and PI3K / AKT Pathways

Qixuan Zhang iD, Zhe Yang, Xiangyang Ou, Mengying Zhang, Rui Ji, Gengxiang Wu

Phytotherapy Research · 2025

DOI: 10.1002/ptr.70100 ↗

At a glance

Journal article in Phytotherapy Research, 2025. Written by Qixuan Zhang and 5 co-authors. Institution: Reproductive Medical Centre, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China. Major MEDLINE topics: Polycystic Ovary Syndrome, Oxidative Stress, Apoptosis, Hesperidin. Cited 7 times so far (Crossref); 83 references. Funded by: National Natural Science Foundation of China.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Polycystic ovary syndrome (PCOS) is the most common endocrine‐metabolic disorder syndrome in women of childbearing age. Hesperidin (HES), a phytoflavonoid glycoside found in citrus fruits such as oranges and lemons, has a variety of pharmacological effects. HES has been extensively studied to protect a variety of tissues from oxidative damage. However, it is not known whether HES may have a therapeutic effect on PCOS. In this study, potential therapeutic targets for HES treatment of PCOS were identified through network pharmacology, altered phosphorylation modification of JAK2 and PI3K was verified in granular cells of PCOS patients, and the mechanism of HES treatment of PCOS was revealed through in vivo and in vitro experiments. Based on network‐based pharmacological studies, PI3K/Akt and JAK2/STAT3 pathways are potential pathways for HES treatment of PCOS, and molecular docking results show that JAK2 has the best binding activity with HES. Western blotting results showed that the phosphorylation modification of JAK2 and PI3K in granular cells of PCOS patients was changed. Experiments in KGN cell lines have shown that HES can reduce DHT‐induced oxidative stress and apoptotic damage. Activating JAK2 or inhibiting PI3K can both reverse this therapeutic effect. In vivo experiments have shown similar results. HES affects oxidative stress and apoptosis in PCOS through signaling crosstalk between JAK2/STAT3 and PI3K/AKT pathways.

Subjects

MeSH terms (MEDLINE)

Polycystic Ovary SyndromeOxidative StressApoptosisHesperidinGranulosa CellsFemaleJanus Kinase 2STAT3 Transcription FactorHumansProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesSignal TransductionAnimalsMolecular Docking SimulationPhosphorylationMiceCell LineAdult

Author keywords

JAK2flavonoidhesperidinoxidative stresspolycystic ovary syndrome

Substances

Janus Kinase 2STAT3 Transcription FactorProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesHesperidinJAK2 protein, humanSTAT3 protein, human

Authors and institutions

  • Reproductive Medical Centre, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.
  • Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai, China.
  • Shanghai Key Laboratory of Reproduction and Development, Shanghai, China.

ORCID profiles: Qixuan Zhang

Funding

  • National Natural Science Foundation of China

Cite

APA

Zhang, Q., Yang, Z., Ou, X., Zhang, M., Ji, R., & Wu, G. (2025). Hesperidin Inhibits Oxidative Stress and Apoptosis of Granulosa Cells in Polycystic Ovarian Syndrome Through the JAK2 / STAT3 and PI3K / AKT Pathways. Phytotherapy Research. https://doi.org/10.1002/ptr.70100

Vancouver

Zhang Q, Yang Z, Ou X, Zhang M, Ji R, Wu G. Hesperidin Inhibits Oxidative Stress and Apoptosis of Granulosa Cells in Polycystic Ovarian Syndrome Through the JAK2 / STAT3 and PI3K / AKT Pathways. Phytotherapy Research. 2025. doi:10.1002/ptr.70100

BibTeX
@article{Zhang2025,
  author = {Zhang, Qixuan and Yang, Zhe and Ou, Xiangyang and Zhang, Mengying and Ji, Rui and Wu, Gengxiang},
  title = {Hesperidin Inhibits Oxidative Stress and Apoptosis of Granulosa Cells in Polycystic Ovarian Syndrome Through the JAK2 / STAT3 and PI3K / AKT Pathways},
  journal = {Phytotherapy Research},
  year = {2025},
  doi = {10.1002/ptr.70100}
}
Start for free →